Acrobiosystems Co.Ltd. (301080.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · China
Acrobiosystems Co.Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 645.02 m CNY | 838.12 m CNY |
| Gross profit | 586.54 m CNY | 763.99 m CNY |
| Operating income | 109.32 m CNY | 196.96 m CNY |
| EBIT | 128.46 m CNY | 172.01 m CNY |
| Net income | 123.83 m CNY | 165.57 m CNY |
| Diluted EPS – continuing operations | 1.03 CNY | 0.99 CNY |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Acrobiosystems Co.Ltd.
Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions. It provides kits, scientific services, and other related products under the Resilient Supply, CytoPak, SAFENSURE, FLAG, Star Staining, Aneuro, ComboX, and GENPower brands. The company also offers cell therapies, gene therapies, therapeutic antibodies, antibody-drug conjugates, core reagents for infectious disease research, and solutions for metabolic and autoimmune disease drug development. In addition, it provides custom reagent, assay development, and analytical services. Further, the company is involved in general business, sales and technical services of biological products, manufacture and sells medical devices, research and development of biological reagent products, business information consulting and conference, and company testing service businesses. The company's products are used in drug screening and optimization for diseases such as cancer, autoimmune diseases, cardiovascular diseases, and infectious diseases; diagnostic reagent development and optimization; preclinical and clinical trials; and drug manufacturing processes and process control. Acrobiosystems Co.,Ltd. was founded in 2010 and is based in Beijing, China.
More stocks
- Iguatemi S.A. (IGTI4.SA)
- Yili Chuanning Biotechnology Co. Ltd. A (301301.SZ)
- Pebblebrook Hotel Trust (PEB)
- China Resources Double-Crane Pharmaceutical Co Ltd (600062.SS)
- Dongguan Dingtong Precision Metal Co. Ltd. A (688668.SS)
- BANNER CORP (BANR)
- Henan Huanghe Whirlwind Co Ltd (600172.SS)
- Navigator Company SA (NVG.LS)
- Shaanxi Huaqin Technology Industry Co. Ltd. A (688281.SS)
- Jinhui Mining Co Ltd (603132.SS)
- CECONOMY (CEC.DE)
- Sumber Global Energy Tbk Pt (SGER.JK)
Not investment advice. All data without warranty, price as of 27.10.2026. Details in the risk notice.